Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/s41594-018-0164-z.

Title:
Structural and molecular mechanisms for the control of eukaryotic 5′–3′ mRNA decay | Nature Structural & Molecular Biology
Description:
5′–3′ RNA decay pathways are critical for quality control and regulation of gene expression. Structural and biochemical studies have provided insights into the key nucleases that carry out deadenylation, decapping, and exonucleolysis during 5′–3′ decay, but detailed understanding of how these activities are coordinated is only beginning to emerge. Here we review recent mechanistic insights into the control of 5′–3′ RNA decay, including coupling between translation and decay, coordination between the complexes and activities that process 5′ and 3′ RNA termini, conformational control of enzymatic activity, liquid phase separation, and RNA modifications. This Review discusses mechanistic insights into 5´–3´ RNA decay, such as translation–decay coupling, coordination between complexes that process 5´ & 3´ RNA termini, conformational control of enzymatic activity, phase separation, & RNA modifications.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Business & Finance
  • Telecommunications

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,058 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,617 per month.

Keywords {🔍}

pubmed, google, scholar, cas, central, mrna, cell, rna, mol, decapping, biol, nature, complex, nat, decay, structural, article, struct, eukaryotic, dcp, control, gene, translation, ccrnot, gross, deadenylation, access, protein, stability, rev, reveals, molecular, coller, expression, basis, structure, parker, res, content, biology, regulation, sci, degradation, nucleic, acids, cookies, analysis, december, biochem, mrnas,

Topics {✒️}

ribosome-ski2-ski3-ski8 helicase complex nature portfolio journals permissions reprints nature portfolio privacy policy advertising scrna-seq data reveals social media dcp2 c-terminal domain author information authors dcp2-dcp1 mrna-decapping complex nature+ nature 461 nature 541 nature 505 nature microrna-mediated gene silencing nonsense-mediated mrna decay /ddx6/cnot1 complex reveals author correspondence p-body purification reveals transcriptional n6-adenosine methylation mirna-mediated gene silencing rna-mediated gene silencing rna-binding protein gigyf2 n6-methyladenosine-dependent regulation nuclease complex stimulated nuclear mrna decay marbles directly interacts permissions personal data springerlink instant access genome-wide mapping genome-wide determination translational mrna decay cotranslational rna decay data protection eukaryotic yth domain messenger rna stability quantifying 3′utr length cellular phase-transition process cleaved transcripts reveals selective mrna decay au-rich elements privacy disordered protein regions ddx6-cnot1 complex promote translational silencing eukaryotic gene expression dhh1 engages pat1

Questions {❓}

  • AU-rich elements and associated factors: are there unifying principles?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Structural and molecular mechanisms for the control of eukaryotic 5′–3′ mRNA decay
         description:5′–3′ RNA decay pathways are critical for quality control and regulation of gene expression. Structural and biochemical studies have provided insights into the key nucleases that carry out deadenylation, decapping, and exonucleolysis during 5′–3′ decay, but detailed understanding of how these activities are coordinated is only beginning to emerge. Here we review recent mechanistic insights into the control of 5′–3′ RNA decay, including coupling between translation and decay, coordination between the complexes and activities that process 5′ and 3′ RNA termini, conformational control of enzymatic activity, liquid phase separation, and RNA modifications. This Review discusses mechanistic insights into 5´–3´ RNA decay, such as translation–decay coupling, coordination between complexes that process 5´ & 3´ RNA termini, conformational control of enzymatic activity, phase separation, & RNA modifications.
         datePublished:2018-12-05T00:00:00Z
         dateModified:2018-12-21T00:00:00Z
         pageStart:1077
         pageEnd:1085
         sameAs:https://doi.org/10.1038/s41594-018-0164-z
         keywords:
            Ribosome
            RNA
            RNA decay
            RNA modification
            Structural biology
            Life Sciences
            general
            Biochemistry
            Protein Structure
            Membrane Biology
            Biological Microscopy
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig5_HTML.png
         isPartOf:
            name:Nature Structural & Molecular Biology
            issn:
               1545-9985
               1545-9993
            volumeNumber:25
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Jeffrey S. Mugridge
               affiliation:
                     name:University of California, San Francisco
                     address:
                        name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jeff Coller
               url:http://orcid.org/0000-0001-5662-8110
               affiliation:
                     name:Case Western Reserve University
                     address:
                        name:The Center for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John D. Gross
               url:http://orcid.org/0000-0002-1377-4705
               affiliation:
                     name:University of California, San Francisco
                     address:
                        name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Structural and molecular mechanisms for the control of eukaryotic 5′–3′ mRNA decay
      description:5′–3′ RNA decay pathways are critical for quality control and regulation of gene expression. Structural and biochemical studies have provided insights into the key nucleases that carry out deadenylation, decapping, and exonucleolysis during 5′–3′ decay, but detailed understanding of how these activities are coordinated is only beginning to emerge. Here we review recent mechanistic insights into the control of 5′–3′ RNA decay, including coupling between translation and decay, coordination between the complexes and activities that process 5′ and 3′ RNA termini, conformational control of enzymatic activity, liquid phase separation, and RNA modifications. This Review discusses mechanistic insights into 5´–3´ RNA decay, such as translation–decay coupling, coordination between complexes that process 5´ & 3´ RNA termini, conformational control of enzymatic activity, phase separation, & RNA modifications.
      datePublished:2018-12-05T00:00:00Z
      dateModified:2018-12-21T00:00:00Z
      pageStart:1077
      pageEnd:1085
      sameAs:https://doi.org/10.1038/s41594-018-0164-z
      keywords:
         Ribosome
         RNA
         RNA decay
         RNA modification
         Structural biology
         Life Sciences
         general
         Biochemistry
         Protein Structure
         Membrane Biology
         Biological Microscopy
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41594-018-0164-z/MediaObjects/41594_2018_164_Fig5_HTML.png
      isPartOf:
         name:Nature Structural & Molecular Biology
         issn:
            1545-9985
            1545-9993
         volumeNumber:25
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Jeffrey S. Mugridge
            affiliation:
                  name:University of California, San Francisco
                  address:
                     name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jeff Coller
            url:http://orcid.org/0000-0001-5662-8110
            affiliation:
                  name:Case Western Reserve University
                  address:
                     name:The Center for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John D. Gross
            url:http://orcid.org/0000-0002-1377-4705
            affiliation:
                  name:University of California, San Francisco
                  address:
                     name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature Structural & Molecular Biology
      issn:
         1545-9985
         1545-9993
      volumeNumber:25
Organization:
      name:Nature Publishing Group US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of California, San Francisco
      address:
         name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
         type:PostalAddress
      name:Case Western Reserve University
      address:
         name:The Center for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, USA
         type:PostalAddress
      name:University of California, San Francisco
      address:
         name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Jeffrey S. Mugridge
      affiliation:
            name:University of California, San Francisco
            address:
               name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Jeff Coller
      url:http://orcid.org/0000-0001-5662-8110
      affiliation:
            name:Case Western Reserve University
            address:
               name:The Center for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, USA
               type:PostalAddress
            type:Organization
      name:John D. Gross
      url:http://orcid.org/0000-0002-1377-4705
      affiliation:
            name:University of California, San Francisco
            address:
               name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
      name:The Center for RNA Science and Therapeutics, Case Western Reserve University, Cleveland, USA
      name:Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

Social Networks {👍}(1)

External Links {🔗}(322)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {📦}

  • Crossref

4.62s.